Why is it Necessary to Understand the Molecular Biologist ? Marília Cravo, M.D., Ph.D. Centro de Nutrição e Metabolismo, Faculdade de Medicina de Lisboa, Portugal phone +351-21-7200422, fax +351-21-7229855, email: mcravo.cplancha@mail.telepac.pt Learning Objectives To get acquainted with the terminology and technology of medical genetics To understand what genetic polymorphisms and susceptibility genes are To understand how nutrients can control gene expression To understand what individualised, genetically tailored medicine is Since the 1970s, nearly all avenues of biomedical research have led to the gene, for genes contain the basic information about how a human body carries out its duties from birth to death [1]. During lifetime, the health of an individual will be determined by the interaction between his genetic background and a number of environmental factors. Nutrition is one of the environmental factors of major importance. DNA Analysis Technology and its Potential Application to Clinical Practice In the year 2001, the Human Genome Project was completed which will revolutionise science and medicine. The transition from genetics to genomics marked the evolution from an understanding of single genes and their individual functions to an understanding of the actions of multiple genes and their control of biologic systems [2]. There was a tremendous improvement in DNA technology in the past few years. Whereas, at first, the Human Genome Project mainly focused on identifying single genes, it rapidly moved to the genomic-scale analysis of the human organism. The so-called DNA chip technology currently provides one promising approach to genome-scale studies of genetic variation, mutation analysis and gene expression [3]. The result of an adaptation of dot blot hybridization techniques, DNA chips, also called microarrays, generally consist of a thin slice of glass or silicon usually about the size of a postage stamp on which threads of synthetic nucleic acid are arrayed. Samples probes are then added to the chip, and matches are read by an electronic scanner. The capacity of DNA chips increases constantly so that hundreds of thousands of genes can now be analysed simultaneously on a single chip. Microarray technology has been applied to the detection of DNA variations as well as expression of messenger RNA in individual cells and tissues. As we will see below, microarrays may become widely used in a near future for establishing a person's risk of contracting common, adult-onset disorders. A base-line genome scan could provide helpful information about a person's risk profile and point to the prevention strategies -if available- that should be used. Genetic Variability and Human Diversity The Human Genome Project clearly showed that not all men are created equal (except for identical twins). And the reason for this genetic diversity is due to single base changes scattered throughout the genome [2,4]. There are now thousands of these so-called single nucleotide polymorphisms (SNPs) located in coding and non-coding regions of DNA. Each SNP can be classified by whether they alter the sequence of the protein encoded by the altered gene. Changes that alter protein sequences can be classified by their effects on protein structure. And non-coding SNPs can be classified according to whether they are found in gene-regulating segments of the genome - many complex diseases may arise from quantitative, rather than qualitative, differences in gene products [2]. More important than just identifying these SNPs, was the discovery that these variations in genome sequences underlie differences in our susceptibility to, or protection from, all kinds of diseases, in the age of onset and severity of illness and in the way our bodies respond to treatment, namely to nutritional challenges. These are called susceptibility genes and they explain different patterns of responses, observed in different individuals, to the same nutritional challenges. Thus, in respect to choleterol metabolism, McCombs and coworkers [5] showed that the apo A-IV-2 allele attenuates the hypercholesterolemic response to the short-term ingestion of a very-high cholesterol diet, whereas Bouchard et al [6] observed that the response to long-term overfeeding differed greatly among different individuals, but very little between identical twins [6]. We may antecipate that studies of SNPs and diseases will be a high topic for research in the forthcoming years. Such research will be the basis for «genetic medicine» in which knowledge or our uniqueness will alter many aspects of medicine. By identifying variation across the whole genome, the SNP map may be our best route to a better understanding of the roles of nature and (not versus) nurture [2]. It is now widely accepted that the large difference in the tolerance of and needs for nutrients observed in different individuals, can be largely accounted by the diversity observed in their genetic heritage [7]. Levels of nutritional intervention Nowadays, we may identify several levels of nutritional intervention: in the community, in the family, as a human being, at the level of body systems, organ, tissue, cell, organelle, and finally, at the molecular level. Changing nutrient composition of foods through biotechnology may alter nutrient interactions, nutrient-gene interactions, nutrient bioavailabilty, nutrient potency and nutrient metabolism. Pediatrics will be one of the first medical specialities to benefit from the outcome of this project, as recombinant DNA manipulations will replace diet therapies [8]. This is especially true as more emphasis is placed on the prevention, rather than the treatment, of chronic degenerative and metabolic diseases. There is a new emerging field of biotechnology and potential nutritional implications for children. The tools of biotechnology have enormous potential to develop new, safe, and nutritious foods that could benefit the immediate and long-term nutritional and health needs of the pediatric population. Coming down to a molecular level, the topic of my talk, the effects of nutrition can be exerted at many stages between transcription of the genetic sequence and production of a functional protein. Nutrition has a marked influence on gene expression and an understanding of the interaction between nutrients and gene expression is important in order to provide a basis for determining the nutritional requirements on an individual basis. For this reason, the regulation of gene expression by specific nutrients is a major aspect of modern nutrition. An example of this was given by Jean Girard in his recent review on the regulation of gene expression by nutrients [9] and consists in the inhibition of cholesterol biosynthesis by excess cholesterol. Previous studies showed that the transcription of a number of genes involved in both cholesterol biosynthesis and in the cellular uptake of cholesterol-rich low density lipoprotein is inhibited by dietary sterols. This is performed by a unique transcription factor named sterol regulatory element binding protein (SREBP) which is turned on and off according to levels of circulating cholesterol. In this same issue of Current Opinion in Clinical Nutrition and Metabolic Care [10,11,12], there are five more reviews illustrating how several nutrients namely, glucose, long-chain fatty acids, arginine and vitamins A and D, regulate the expression of several genes. Moreover, besides influencing gene expression at a transcriptional level, dietary factors, both macro- and micronutrients, can also exert an effect at the post-translational level, particularly mRNA stability. In a recent review, Hesketh and colleagues [13], present the effect of several nutrients on the regulation of gene expression by post-transcriptional mechanisms. The function of the regulatory signals in the untranslated regions of the mRNA is highlighted in relation to control of mRNA stability. It is concluded that nutrients can influence gene expression through control of the regulatory signals in these untranslated regions and that the post-transcriptional regulation of gene expression by these mechanisms may influence nutritional requirements [13]. There are a number of other examples clearly showing that regulation of gene expression by nutrients in mammals is an important mechanism allowing them to adapt to the nutritional environment. Why Do Nutrition Professionals Need to Understand the Molecular Biologist? Identifying human genetic variations and their relations to clinical phenotypic, will eventually allow physicians to adapt therapies, including nutritional care, to the individual patient. There may be treatments which are efficient in some patients, which carry some specific genetic traits, and largely inefficient in others who have a different genetic background. These observations led to the development of a new field of pharmacogenomics, which attempts to use information about genetic variation to predict responses to drug or nutritional therapies [1]. In the next decade or so, we can imagine a scenario where, there will be the so-called genetically based, individualised preventive medicine, according to which a number of preventive strategies, including nutritional intervention, will be tailored for each specific individual, according to his genetic background. For this to happen it will be necessary that physicians, dietitians, nurses and other health care providers become familiar with the emerging field of genetics. Not only with its broad contents but also with its language, the methodologies used, as well as with its limitations. There will still be specialists on the matter who will be needed to solve the more complex problems, but genetic medicine will be practiced for the most part by primary care providers. In this respect, a number of surveys have shown that currently we are not prepared for this since a large proportion of medical doctors did not receive genetics as part as their formal training. To meet this urgent need for education in medical genetics, the National Coalition for Health Professional Education in Genetics has been created (NCHPEG accessible at http://www.nchpeg.org) with the aim of promoting professional education and access to information about advances in human genetics [1]. References 1. Collins FS. Shattuck Lecture - Medical and societal consequences of the Human Genome Project. N Engl J Med 1999; 341;1: 28-37 2. Chakravarti A...to a future of genetic medicine.. Nature 2001;409: 822-3 3. Wang DG, Fan J-B, Siao C-J et al. Large scale identification, mapping and genotyping of a single-nucleotide polymorphisms in the human genome. Science 1998; 280:1077-82 4. Collins FS, Guyer MS, Chakravarti A. Variations on a Theme: cataloging human DNA sequence variation. Science 1997; 278:1580-1 5. McComb RJ, Marcadis DE, Ellis J, Weinerg RB. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 1994; 331:706-10 6. 7. 8. 9. 10. 11. 12. 13. Bouchard C, Tremblay A, Despres J-P et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990. 322: 1477-82 Berdanier CD. Nutrient-gene interactions: today and tomorrow. FASEB J 1994; 8: 1 Young AL, Lewis CG. Biotechnology and potential nutritional implications for children. Pediatr Clin North Am 1995; 42:917-30 Girard J. The regulation of gene expression by nutrients. Curr Opin Clin Nutr Metab Care 1998;1:321-2 Foufelle F, Girard J, Ferre P. Glucose regulation of gene expression. Curr Opin Clin Nutr Metab Care 1998;1:323-8 Pegorier J-P. Regulation of gene expression by fatty acids. Curr Opin Clin Nutr Metab Care 1998;1:329-4 Tissue-selective expression of enzymes of arginine synthesis. Wakabayashi Y. Curr Opin Clin Nutr Metab Care 1998;1:335-9 HeskethJ, Vasconcelos MH, Bermano G. Regulatory signals in messenger RNA: determinants of nutrient-gene interaction and metabolic compartmentation. Br J Nutr 1998; 80: 307-21